Commandité
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Posté
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Rechercher
Catégories
- National
- International
- Business
- Technology
- Health
- Éducation
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Lire la suite
IND vs ENG 3rd Test: Workload or lack of support?
Jasprit Bumrah's workload management has sparked debate, contrasting with Kapil Dev's era....
Aditya 's Metro In Dino Set to Surpass Ok Jaanu's Lifetime Collection
Aditya Roy Kapur's Metro In Dino performs well. The film earns Rs 22.15 crore in five days. It...
IND vs ENG: 'Who would want to be a bowler?' – Pat Cummins slams Edgbaston pitch with nearly 1700 runs scored
Following India's dominant 336-run victory over England at Edgbaston, Australia's captain Pat...
IND vs ENG 3rd Test: Upbeat Bumrah goes through the paces at Lord's
Ahead of the third Test at Lord's, Jasprit Bumrah fine-tuned his bowling with subtle adjustments...
© 2025 Dununu.com : Circle of Life - Santan Social Network
French
